Table 4.
Variable | 3‐year OS (%) | P | 3‐year RFS (%) | P |
---|---|---|---|---|
Air bronchogram type | 91.7 | 0.029 | 83.3 | 0.04 |
Non‐air bronchogram type | 49.6 | 49.7 | ||
GGO type | 100 | 0.176 | 100 | 0.100 |
Non‐GGO type | 53.9 | 47 | ||
Pathological stage | ||||
I & II | 86.7 | 0.01 | 75.0 | 0.117 |
III | 37.5 | 39.8 | ||
Lymph node metastasis | ||||
Negative | 81.4 | 0.03 | 68.6 | 0.405 |
Positive | 45.5 | 46.8 | ||
Tumor size | ||||
≤ 5 cm | 71.8 | 0.182 | 68.3 | |
> 5 cm | 50.0 | 33.3 | ||
Adenocarcinoma component | ||||
Yes | 83.3 | 0.626 | 67.2 | 0.027 |
No | 68.8 | 50.0 | ||
Adjuvant therapy | ||||
Yes | 50.9 | 0.238 | 51.6 | 0.173 |
No | 80.1 | 71.5 |
AB, air bronchogram; GGO, ground glass opacity.; OS, overall survival; RFS, recurrence‐free survival.